Microbiology, Mycobacterium tuberculosis, Efflux, Gene and Drug resistance are her primary areas of study. Her Microbiology research is multidisciplinary, incorporating perspectives in Burkholderia cenocepacia and Mycobacterium. The concepts of her Mycobacterium tuberculosis study are interwoven with issues in Genetics, Mycobacterium Tuberculosis Structural Genomics Consortium and Intracellular parasite.
Her work deals with themes such as Multiple drug resistance and Antibacterial agent, which intersect with Efflux. Her research investigates the connection between Gene and topics such as Ethidium bromide that intersect with issues in Transmembrane domain, Intracellular, Peptide sequence, Molecular biology and Acriflavine. Her work is dedicated to discovering how Drug resistance, Antibiotics are connected with Quorum sensing, Bacterial genetics and Membrane transport protein and other disciplines.
Giovanna Riccardi spends much of her time researching Microbiology, Mycobacterium tuberculosis, Biochemistry, Gene and Molecular biology. Her Microbiology research incorporates themes from Efflux, Burkholderia cenocepacia and Bacteria. She works mostly in the field of Efflux, limiting it down to concerns involving Drug resistance and, occasionally, Antibiotics.
Her study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Computational biology, Pharmacology and Mycobacterium. Her Gene study deals with the bigger picture of Genetics. Her Molecular biology study combines topics from a wide range of disciplines, such as Plasmid, DNA, Coding region, Escherichia coli and Molecular cloning.
Her scientific interests lie mostly in Burkholderia cenocepacia, Microbiology, Biochemistry, Drug discovery and Drug resistance. Giovanna Riccardi has researched Burkholderia cenocepacia in several fields, including Quorum sensing, FtsZ, FtsA and Bacterial cell structure. Giovanna Riccardi merges Microbiology with Drug delivery in her study.
Her studies deal with areas such as Prodrug, Drug development, Computational biology and Intensive care medicine as well as Drug discovery. Her Drug resistance research incorporates elements of Efflux and Antibiotic resistance. Giovanna Riccardi combines topics linked to Mutant with her work on Mycobacterium tuberculosis.
Her primary scientific interests are in Drug discovery, Computational biology, CTP synthetase, Mycobacterium tuberculosis and Prodrug. Her Drug discovery research integrates issues from Drug development and Drug. The study incorporates disciplines such as In silico and Enzyme in addition to Computational biology.
She has included themes like Ethionamide, Bioavailability, Distribution and Isoniazid in her Prodrug study. Giovanna Riccardi combines Context and Biochemistry in her research. Her Biochemistry research includes themes of Microbiology, In vivo and Biofilm.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov;Giulia Manina;Katarina Mikusova;Ute Möllmann.
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Edda De Rossi;José A. Aínsa;Giovanna Riccardi.
Fems Microbiology Reviews (2006)
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors.
Thierry Christophe;Mary Jackson;Hee Kyoung Jeon;Denis Fenistein.
PLOS Pathogens (2009)
Global Analysis of the Mycobacterium tuberculosis Zur (FurB) Regulon
Anna Maciag;Elisa Dainese;G. Marcela Rodriguez;Anna Milano.
Journal of Bacteriology (2007)
Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis
Maria Rosalia Pasca;Paola Guglierame;Fabio Arcesi;Marco Bellinzoni.
Antimicrobial Agents and Chemotherapy (2004)
Antibiotic resistance of benthic bacteria in fish-farm and control sediments of the Western Mediterranean
Elisabetta Chelossi;Luigi Vezzulli;Anna Milano;Manuela Branzoni.
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
Claudia Trefzer;Henrieta Škovierová;Silvia Buroni;Adela Bobovská.
Journal of the American Chemical Society (2012)
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.
Anna Milano;Maria Rosalia Pasca;Roberta Provvedi;Anna Paola Lucarelli.
mmpL7 Gene of Mycobacterium tuberculosis Is Responsible for Isoniazid Efflux in Mycobacterium smegmatis
Maria R. Pasca;Paola Guglierame;Edda De Rossi;Francesca Zara.
Antimicrobial Agents and Chemotherapy (2005)
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium Tuberculosis.
João Neres;Florence Pojer;Elisabetta Molteni;Laurent R. Chiarelli.
Science Translational Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: